Proteon Pharmaceuticals Revenue and Competitors

Claim your profile

Lodz, Poland



Total Funding



Estimated Revenue & Valuation

  • Proteon Pharmaceuticals's estimated annual revenue is currently $9.1M per year.(i)
  • Proteon Pharmaceuticals's estimated revenue per employee is $77,500

Employee Data

  • Proteon Pharmaceuticals has 118 Employees.(i)
  • Proteon Pharmaceuticals grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Proteon Pharmaceuticals SA is an innovative biotech company using bacteriophages as the foundation for preventing and eradicating bacterial diseases in food animals, humans and plants. Bacteriophages are naturally existing organisms occurring in the microbiome.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Proteon Pharmaceuticals News

2022-04-17 - Biomaterials and biotech converge to fight antibiotic resistance

For years, pharmaceutical companies have tried to keep pace with ... Polish startup Proteon Pharmaceuticals are among the first to make...

2022-04-13 - Proteon Pharma to set up plant in Maharashtra

To produce antibacterial solution for livestock by 2023 and tap neighbouring countries. Poland-based Proteon Pharmaceuticals (India) plans to...

2022-04-13 - Phage Therapy Market Size [2022-2028] | is Projected to Reach USD 100.8 Million, with 17.6% CAGR | Growth Rate, Share, New Developments, Market Dynamics, Key Players, Revenue, and Expansion Plans, Research | Market Reports World

The major key players are - NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences...

2021-08-11 - Nutreco, Polish state fund pump $25m into animal antibiotic alternative Proteon

Animal health giant Nutreco and aquaculture-focused VC firm Aqua-Spark have co-led a €21 million ($24.6 million) investment into Proteon Pharmaceuticals – a Polish startup which is aiming to reduce animal agriculture’s reliance on antibiotics and slow down rising resistance to antimicrobial drug ...

2019-09-08 - Analysts Set Proteon Therapeutics Inc (NASDAQ:PRTO) Price Target at $2.50

Zacks Investment Research cut Proteon Therapeutics from a “buy” rating to a ... focuses on the development of pharmaceuticals to address the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding